William E. Rote
Chief Research Officer at Travere Therapeutics, Inc. (TVTX)
William E. Rote has filed 29 insider reports with the SEC since January 2021, as chief Research Officer at Travere Therapeutics, Inc. (TVTX). In the last 12 months William E. Rote sold $16.4M of stock on the open market. In the latest filing, on September 18, 2026, William E. Rote sold 209,048 shares of Travere Therapeutics, Inc. (TVTX) for $13.1M at an average of $62.83.
- Filings
- 29
- Companies
- 1
- Bought on market
- None
- Sold on market
- $17.8M
Companies where William E. Rote is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Research Officer | 98,197 | $17.8M | $50.24 | Sep 18, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 16, 2026-$13.1MTVTXChief Research Officer Rote William E. exercised 191,500 shares at a strike of $21.40 and sold $13,135,397 worth of shares (209,048 units at $62.83) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 98,197 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 6, 2026-$121KTVTXChief Research Officer Rote William E. converted options into 4,250 shares and sold $121,434 worth of shares (2,763 units at $43.95) as part of a pre-agreed trading plan, increasing direct ownership by 1% to 115,474 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Apr 22, 2026-$356KTVTXChief Research Officer Rote William E. sold $355,719 worth of shares (9,100 units at $39.09) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 113,987 unitsForm 4Open-market sale10b5-1 plan
- Apr 13, 2026TVTXSEC Form 4 filed by Rote William E.Form 4Grant or award
- Feb 3, 2026-$409KTVTXChief Research Officer Rote William E. was granted 20,090 shares and sold $409,100 worth of shares (12,446 units at $32.87), increasing direct ownership by 8% to 109,087 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Dec 24, 2025-$2.41MTVTXChief Research Officer Rote William E. exercised 60,000 shares at a strike of $20.61 and sold $2,406,180 worth of shares (60,000 units at $40.10)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- May 5, 2025-$67.3KTVTXChief Research Officer Rote William E. converted options into 4,920 shares and sold $67,318 worth of shares (3,198 units at $21.05), increasing direct ownership by 2% to 100,241 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 12, 2025-$122KTVTXSENIOR VICE PRESIDENT, R&D Rote William E. converted options into 8,000 shares and sold $122,356 worth of shares (5,200 units at $23.53), increasing direct ownership by 3% to 98,519 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 3, 2025-$177KTVTXSENIOR VICE PRESIDENT, R&D Rote William E. sold $177,051 worth of shares (8,951 units at $19.78) and was granted 21,500 shares, increasing direct ownership by 15% to 95,719 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jan 22, 2025-$47.4KTVTXSENIOR VICE PRESIDENT, R&D Rote William E. sold $47,424 worth of shares (2,437 units at $19.46), decreasing direct ownership by 3% to 83,170 unitsForm 4Open-market sale10b5-1 plan
- Sep 9, 2024-$50.5KTVTXSENIOR VICE PRESIDENT, R&D Rote William E. was granted 6,750 shares and sold $50,538 worth of shares (4,387 units at $11.52), increasing direct ownership by 3% to 84,455 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Feb 1, 2024-$41.5KTVTXRote William E. was granted 25,000 shares and sold $41,495 worth of shares (4,764 units at $8.71), increasing direct ownership by 33% to 80,720 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jan 23, 2024-$18.5KTVTXRote William E. sold $18,476 worth of shares (2,062 units at $8.96), decreasing direct ownership by 3% to 60,484 unitsForm 4Open-market sale10b5-1 plan
- Sep 5, 2023-$26.7KTVTXSEC Form 4: Rote William E. sold $26,699 worth of shares (1,815 units at $14.71) and was granted 3,300 shares, increasing direct ownership by 2% to 61,173 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- May 10, 2023-$13.7KTVTXSEC Form 4 filed by Rote William E.Form 4Open-market sale10b5-1 plan
- Feb 1, 2023-$57.6KTVTXSEC Form 4: Rote William E. was granted 20,250 shares and sold $57,628 worth of shares (2,590 units at $22.25) as part of a pre-agreed trading plan, increasing direct ownership by 42% to 60,036 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jan 24, 2023-$44.3KTVTXSEC Form 4: Rote William E. sold $44,333 worth of shares (2,062 units at $21.50) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 42,376 unitsForm 4Open-market sale10b5-1 plan
- May 11, 2022-$33.9KTVTXSEC Form 4: Rote William E. sold $33,940 worth of shares (1,563 units at $21.71) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 43,672 unitsForm 4Open-market sale10b5-1 plan
- Jan 31, 2022-$30.8KTVTXSEC Form 4: Rote William E. was granted 9,840 shares and sold $30,825 worth of shares (1,125 units at $27.40) as part of a pre-agreed trading plan, increasing direct ownership by 24% to 45,235 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jan 24, 2022-$46.8KTVTXSEC Form 4: Rote William E. sold $46,838 worth of shares (1,875 units at $24.98) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 36,520 unitsForm 4Open-market sale10b5-1 plan
- Jan 11, 2022-$68.5KTVTXSEC Form 4: Rote William E. was granted 5,000 shares and sold $68,500 worth of shares (2,500 units at $27.40) as part of a pre-agreed trading plan, increasing direct ownership by 7% to 38,395 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Aug 17, 2021-$24.1KTVTXSEC Form 4: ROTE WILLIAM E. was granted 4,500 units of Common Stock and sold $24,085 worth of Common Stock (1,407 units at $17.12), increasing direct ownership by 9% to 35,731 units (for withholding tax)Form 4Grant or awardOpen-market sale
- May 12, 2021-$60.3KTVTXSEC Form 4: ROTE WILLIAM E. sold $60,312 worth of Common Stock (3,125 units at $19.30), decreasing direct ownership by 9% to 31,707 unitsForm 4Open-market sale10b5-1 plan
- Feb 18, 2021-$70KTVTXSEC Form 4: E. William Rote sold $70,025 worth of Common Stock (2,500 units at $28.01), decreasing ownership by 7% to 34,832 unitsForm 4Open-market sale10b5-1 plan
- Feb 8, 2021-$142KTVTXSEC Form 4: E. William Rote sold $141,728 worth of Common Stock (4,500 units at $31.50), decreasing ownership by 11% to 37,332 unitsForm 4Open-market sale10b5-1 plan
- Feb 3, 2021TVTXSEC Form 4: E. William Rote was granted 4,500 units of Common Stock, increasing ownership by 12% to 41,832 unitsForm 4Grant or award
- Feb 3, 2021-$105KTVTXSEC Form 4: E. William Rote sold $104,799 worth of Common Stock (3,625 units at $28.91), decreasing ownership by 9% to 37,332 unitsForm 4Open-market sale10b5-1 plan
- Feb 2, 2021-$111KTVTXSEC Form 4: E. William Rote was granted 5,000 units of Common Stock and sold $111,469 worth of Common Stock (3,625 units at $30.75), increasing ownership by 10% to 43,457 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Jan 21, 2021TVTXSEC Form 4: E. William Rote was granted 15,000 units of Common Stock, increasing ownership by 61% to 39,582 unitsForm 4Grant or award
Compare William E. Rote with
- William E. Rote vs Peter Heerma1 shared
- William E. Rote vs Jula Inrig1 shared
- William E. Rote vs Elizabeth E Reed1 shared
- William E. Rote vs Eric M Dube1 shared
- William E. Rote vs Christopher R. Cline1 shared
- William E. Rote vs Sandra Calvin1 shared
Other insiders at the same companies
- Peter HeermaTVTX
- Jula InrigTVTX
- Elizabeth E ReedTVTX
- Eric M DubeTVTX
- Christopher R. ClineTVTX
- Sandra CalvinTVTX
- Jeffrey A MecklerTVTX
- Gary A LyonsTVTX
- Timothy CoughlinTVTX
- Roy D. BaynesTVTX
- Brinkley Ruth WilliamsTVTX
- John A OrwinTVTX
- Sandra PooleTVTX
- Ron SquarerTVTX
- Suzanne Louise BruhnTVTX
Questions about William E. Rote
- What is William E. Rote's role at Travere Therapeutics, Inc.?
- William E. Rote reports to the SEC as chief Research Officer at Travere Therapeutics, Inc. (TVTX), according to the latest filing on September 18, 2026.
- How many shares does William E. Rote own?
- After the latest filing that states it, William E. Rote directly owned 98,197 shares of Travere Therapeutics, Inc. (TVTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has William E. Rote bought or sold stock recently?
- The most recent open-market sale was on September 16, 2026: sold 209,048 shares of Travere Therapeutics, Inc. (TVTX) for $13.1M at an average of $62.83.
- How do I get alerts when William E. Rote files?
- Follow William E. Rote on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. William E. Rote filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by William E. Rote (SEC CIK 0001698262). Totals count each trade once, skipping amendments whose original is on file, from Jan 26, 2021 on. View on SEC EDGAR